Compare Research Peptides

Select 2 peptides to compare benefits, dosage, administration routes, mechanisms, and side effect profiles side by side.

Peptide 1

Peptide 2

	Pancragen Pancreatic Bioregulator Sign up to track	Vilon Lys-Glu dipeptide Sign up to track
Evidence Grade	CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data	CEvidenceGrade CPrimarily animal or in-vitro studies; limited human data
Regulatory	Research OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only	Research OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only
Category	Khavinson Bioregulators	Khavinson Bioregulators
Key Benefits	•Supports pancreatic function •Regulates insulin synthesis •May improve glucose metabolism •Supports enzymatic activity +2 more	•Regulates immune system •Anti-aging effects •Supports thymus health •May normalize cortisol +2 more
Dosage	10-20 mg mg	10 mg mg
Frequency	Daily for 10-20 days	Daily for 5-10 days per month
Administration	Oral	SubcutaneousOral
Mechanism	Pancragen is a Khavinson bioregulator tetrapeptide that regulates insulin synthesis and supports pancreatic function. It may improve glucose metabolism and maintain pancreatic cell health.	Vilon is a Khavinson bioregulator consisting of two amino acids (Lys-Glu). It regulates thymus and immune system function, with anti-aging and geroprotective properties.
Side Effects / Risks	Not specified	Not specified
Research Status	Khavinson bioregulator - Russian research	Research compound